DK139429C - - Google Patents

Info

Publication number
DK139429C
DK139429C DK495775A DK495775A DK139429C DK 139429 C DK139429 C DK 139429C DK 495775 A DK495775 A DK 495775A DK 495775 A DK495775 A DK 495775A DK 139429 C DK139429 C DK 139429C
Authority
DK
Denmark
Application number
DK495775A
Other languages
Danish (da)
Other versions
DK139429B (da
DK495775A (zh
Inventor
C L Zirkle
Original Assignee
Smithkline Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corporation filed Critical Smithkline Corporation
Publication of DK495775A publication Critical patent/DK495775A/da
Publication of DK139429B publication Critical patent/DK139429B/da
Application granted granted Critical
Publication of DK139429C publication Critical patent/DK139429C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK495775AA 1974-11-06 1975-11-04 Analogifremgangsmåde til fremstilling af 1-methylpiperidinforbindelser, der i 4-stillingen er substitueret med en dobbeltbundet tricyklisk gruppe. DK139429B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52121674A 1974-11-06 1974-11-06

Publications (3)

Publication Number Publication Date
DK495775A DK495775A (zh) 1976-05-07
DK139429B DK139429B (da) 1979-02-19
DK139429C true DK139429C (zh) 1979-08-06

Family

ID=24075868

Family Applications (1)

Application Number Title Priority Date Filing Date
DK495775AA DK139429B (da) 1974-11-06 1975-11-04 Analogifremgangsmåde til fremstilling af 1-methylpiperidinforbindelser, der i 4-stillingen er substitueret med en dobbeltbundet tricyklisk gruppe.

Country Status (17)

Country Link
JP (1) JPS5826754B2 (zh)
AU (1) AU498298B2 (zh)
BE (1) BE835224A (zh)
CA (1) CA1055945A (zh)
CH (1) CH624403A5 (zh)
DE (1) DE2549841A1 (zh)
DK (1) DK139429B (zh)
ES (1) ES442357A1 (zh)
FR (1) FR2290202A1 (zh)
HU (1) HU174639B (zh)
IE (1) IE42137B1 (zh)
IL (1) IL48400A (zh)
LU (1) LU73714A1 (zh)
NL (1) NL7512974A (zh)
NZ (1) NZ179139A (zh)
PH (1) PH12158A (zh)
ZA (1) ZA756550B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2357251A1 (fr) * 1976-07-09 1978-02-03 Merck & Co Inc 1-methyl-4-(2-carboxy-1-thioxanthan-9-ylidene)-piperidine
US4073912A (en) * 1976-10-12 1978-02-14 Smithkline Corporation Piperidylidene derivatives of benzo-fused xanthenes, thioxanthenes and dibenzoxepins and antipsychotic use thereof
US4089961A (en) * 1976-11-08 1978-05-16 Smithkline Corporation Antipsychotically useful quinolizidylidene derivatives of xanthenes, thioxanthenes and dibenzoxepins
NZ189108A (en) * 1977-12-29 1982-02-23 Kefalas As 2-methylthio-6-fluoro-9-(1-methyl-4-piperidylidene)-thioxanthene and pharmaceutical compositions intermediate 2-methylthio-6-fluoro-9-(1-methyl-4-piperidyl)-thioxanthen-9-ol
US4777177A (en) * 1984-10-19 1988-10-11 Ciba-Geigy Corporation Pesticidal thioxanthen-9-ylidenepiperidines
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
CA2004211A1 (en) * 1988-11-30 1990-05-31 Masataka Syoji Piperidine derivatives and hyportensives containing the same
EP1306376A1 (en) * 2001-10-25 2003-05-02 Biofrontera Pharmaceuticals AG Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
US7060711B2 (en) 2001-10-25 2006-06-13 Biofrontera Bioscience Gmbh Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
CA2530444C (en) * 2003-06-27 2012-03-13 Janssen Pharmaceutica, N.V. Tricyclic .delta. opioid modulators
CN101039940A (zh) 2004-08-05 2007-09-19 詹森药业有限公司 三环δ－阿片样物质调节剂
CA2592462A1 (en) * 2004-12-22 2006-06-29 Janssen Pharmaceutica N.V. Tricyclic delta-opioid modulators
EA011674B1 (ru) 2004-12-22 2009-04-28 Янссен Фармацевтика Н.В. ТРИЦИКЛИЧЕСКИЕ δ-ОПИОИДНЫЕ МОДУЛЯТОРЫ
BRPI0519201A2 (pt) 2004-12-22 2008-12-30 Janssen Pharmaceutica Nv moduladores de delta-opiàide tricÍclico
JP2008526878A (ja) 2005-01-06 2008-07-24 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 三環式δ−オピオイド調節剤
BRPI0611885A2 (pt) 2005-06-16 2010-10-05 Janssen Pharmaceutica Nv moduladores opióides tricìclicos
EP2067777B1 (en) 2006-09-29 2013-08-14 Nippon Zoki Pharmaceutical Co., Ltd. Oxepin derivative

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL260070A (zh) * 1960-02-25
NL122808C (zh) * 1961-09-29
DE1670118A1 (de) * 1966-07-22 1970-11-05 Boehringer Mannheim Gmbh Verfahren zur Herstellung neuer Derivate des 6,11-Dihydro-dibenz[b,e]oxepins und ihrer Salze
US3470188A (en) * 1967-01-05 1969-09-30 Smithkline Corp 9-cycloalkyl-lower alkyl-piperidylidene derivatives of xanthenes and thioxanthenes
JPS5018478A (zh) * 1973-05-17 1975-02-26

Also Published As

Publication number Publication date
CA1055945A (en) 1979-06-05
AU8624775A (en) 1977-05-05
HU174639B (hu) 1980-02-28
BE835224A (fr) 1976-05-04
IL48400A0 (en) 1976-01-30
NZ179139A (en) 1978-04-28
NL7512974A (nl) 1976-05-10
ES442357A1 (es) 1977-04-01
FR2290202A1 (fr) 1976-06-04
ZA756550B (en) 1976-09-29
FR2290202B1 (zh) 1980-05-23
JPS5170768A (zh) 1976-06-18
DE2549841C2 (zh) 1988-07-07
IL48400A (en) 1979-01-31
DK139429B (da) 1979-02-19
DK495775A (zh) 1976-05-07
CH624403A5 (en) 1981-07-31
PH12158A (en) 1978-11-10
IE42137B1 (en) 1980-06-04
DE2549841A1 (de) 1976-05-13
IE42137L (en) 1976-05-06
AU498298B2 (en) 1979-03-01
LU73714A1 (zh) 1976-06-11
JPS5826754B2 (ja) 1983-06-04

Similar Documents

Publication Publication Date Title
FR2269851B1 (zh)
FI751959A (zh)
FR2281023B1 (zh)
DK139429C (zh)
FR2273618B1 (zh)
FR2282124B1 (zh)
FR2272596B1 (zh)
FR2287992B1 (zh)
FR2283330B1 (zh)
FR2280137B3 (zh)
CS173305B1 (zh)
CH41675A4 (zh)
BG21352A1 (zh)
CH585880A5 (zh)
CH569666A5 (zh)
CH569220A5 (zh)
CH568539A5 (zh)
CH568134A5 (zh)
CH566915A5 (zh)
CH566410A5 (zh)
CH564833A5 (zh)
CH563933A5 (zh)
CH562521A5 (zh)
CH562462A5 (zh)
DD116735A1 (zh)

Legal Events

Date Code Title Description
PBP Patent lapsed